Valuation (28%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | N/A | 45.61 |
PEG Ratio (TTM) | N/A | 4.63 |
P/S Ratio (TTM) | -6,513.01 | 3.94 |
P/B Ratio (TTM) | N/A | 1.95 |
P/FCF Ratio (TTM) | 0.01 | -40.46 |
Price to 5YR AVG Earnings Ratio | N/A | 52.29 |
Price to 5YR AVG FCF Ratio | 0.06 | 30.87 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | N/A | 1.12% |
ROE (TTM) | N/A | -6.38% |
Net Profit Margin (TTM) | N/A | -0.41% |
ROIC 5YR AVG | N/A | 137.01% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | N/A | N/A | N/A |
Revenue | -25.00% | N/A | N/A |
Net Income | N/A | N/A | N/A |
Cash Flow | 296.37% | N/A | N/A |
Health (35%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.69 | 2.97 |
Quick Ratio (TTM) | 0.08 | 2.89 |
D/E Ratio (TTM) | N/A | 1.15 |
Interest Coverage (TTM) | N/A | -0.85 |
Piotroski F-Score | 5 | 5 |
Altman Z-Score | N/A | 4.40 |
LTL to 5YR AVG FCF | N/A | 51.78 |
Shares Outstanding Growth 5YR AVG | -19.98% | 72.00% |